Production (Stage)
Indaptus Therapeutics, Inc.
INDP
$0.3426
-$0.0007-0.20%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Net Income | -19.06% | -3.20% | 21.76% | -23.73% | 10.50% |
| Total Depreciation and Amortization | -- | -100.00% | -100.00% | -100.00% | 133.33% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -68.90% | -59.21% | -28.84% | 38.00% | 29.57% |
| Change in Net Operating Assets | 16.53% | -34.17% | 125.61% | 32.21% | 30.75% |
| Cash from Operations | -28.21% | -30.51% | 32.71% | -17.62% | 20.67% |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -- | -- | -- | -- | -- |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 936.52% | -- | -- | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -1,556.50% | -- | -- | -- | -- |
| Cash from Financing | 897.28% | -- | -- | -- | -- |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 47.64% | 38.74% | -97.58% | -141.40% | -28.31% |